Professor Nick Alderman
Elysium Neurological, Elysium Healthcare
Professor Nick Alderman BA (Hons) MAppSci PhD CPsychol CSci FBPsS
Professor Nick Alderman is Clinical Director, Neurobehavioral Rehabilitation Services at Elysium Neurological, part of Elysium Healthcare. He is acknowledged internationally as one of the foremost experts in neurobehavioral rehabilitation, having combined successful careers in both clinical and academic psychology.
Previously he held senior posts at St Andrew’s Healthcare (Kemsley Unit), the Brain Injury Rehabilitation Trust, Partnerships in Care and Priory Healthcare. He is Honorary Professor at Swansea University and Visiting Professor at the University of the West of England. In addition, Nick is Chair of the Independent Neurorehabilitation Providers Alliance ‘Research & Outcomes’ group, and Chair of the East Midlands Acquired Brain Injury Forum. Nick has published numerous journal papers and book chapters; has created neuropsychological tests, observational recording measures and outcome measures used in neurorehabilitation services across the world.
He has received many awards in recognition of his work, including the prestigious United Kingdom Acquired Brain Injury Forum ‘Stephen McAleese Award for Inspiration’ in recognition of his work in successfully reducing restrictive interventions in neurobehavioral rehabilitation. Nick is a keen dog owner and prides himself on being an amateur musician of ‘questionable talent’.
Untangling the mystery of how to measure neurobehavioral disability: SASNOS
Neurobehavioral disability (NBD) resulting from acquired brain injury has significant consequences, underpinning challenging behaviour, which is known to be the greatest impediment to community integration. Effective management of NBD increases personal autonomy through reduction of social handicap. However, assessment of NBD has proved problematic, principally because symptoms constitute a diverse, complex, subtle, and pervasive constellation of cognitive-behavioural changes. Standardised measures of NBD have been compiled but suffer from shortcomings that undermine their usefulness. To provide a ‘fit-for-purpose’ assessment tool, the ‘St Andrew’s - Swansea Neurobehavioral Assessment Scale’ (SASNOS) was developed and is available free of charge. In this seminar, attendees will become aware of why and how SASNOS was developed, learn how it is completed, and become familiar with its numerous applications, in particular, how it benefits clinical practice. Finally, progress to date in developing a revised, expanded version of SASNOS in response to user feedback will be shared.
EVEN MORE SEMINARS
Dr Tom Newsom-Davis Leaders in Oncology Care (Part of HCA healthcare UK)
Immunotherapy and innovative systemic treatments in Oncology
Glenn Flux Royal Marsden Hospital
The emergence and resurgence of radiotherapeutics for cancer treatment
Richard Edwards BSc MBBS FRCS FRCS MD Circle Bath Hospital
Stéfan Halbherr InnoMedica
Liposome pipeline addressing unmet medical needs in oncology, imaging, and neurodegeneration
Merina Ahmed Royal Marsden NHS foundation Trust
Stereotactic Radiotherapy for lung tumours and oligometastatic disease